Dates: 01/01/2020
31/12/2023
Topic: Biomarkers identification
Project type: Immunotherapy
Project target: Autoimmune disease
Infectious disease
Financing:
H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being
H2020-EU.3.1.3. – Treating and managing disease
Participating agents:
Radboud University Medical Center
-ELLINIKO INSTITUTO MELETIS TIS SIPSIS
-CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
-UNIVERSITATSKLINIKUM JENA
-ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM
-UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA
-HOSPICES CIVILS DE LYON
-RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN
-CEMM – FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH
-TEL AVIV UNIVERSITY
-BIOMERIEUX SA
-BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
-THE UNIVERSITY OF READING
-EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH
Keywords: sepsis; personalised medicine; immunotherapy; theranostic; biomarker; therapeutic
Countries: Austria; France; Greece; Germany; Israel; Netherlands; Romania; Switzerland; United Kingdom
Project page: Access page
